M. Elhai, C. Meune, J. Avouac, A. Kahan, and Y. Allanore, Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies, Rheumatology, vol.51, issue.6, pp.1017-1043, 2012.
DOI : 10.1093/rheumatology/ker269

A. Gabrielli, E. Avvedimento, T. Krieg, and . Scleroderma, Scleroderma, New England Journal of Medicine, vol.360, issue.19, pp.1989-2003, 2009.
DOI : 10.1056/NEJMra0806188

S. Jordan, J. Chung, and O. Distler, Preclinical and translational research to discover potentially effective antifibrotic therapies in systemic sclerosis, Current Opinion in Rheumatology, vol.25, issue.6, pp.679-85, 2013.
DOI : 10.1097/01.bor.0000434598.51526.0e

J. Avouac, M. Elhai, and Y. Allanore, Experimental models of dermal fibrosis and systemic sclerosis, Joint Bone Spine, vol.80, issue.1, pp.23-31, 2013.
DOI : 10.1016/j.jbspin.2012.06.005

J. Avouac, K. Palumbo-zerr, N. Ruzehaji, M. Tomcik, P. Zerr et al., The Nuclear Receptor Constitutive Androstane Receptor/NR1I3 Enhances the Profibrotic Effects of Transforming Growth Factor ?? and Contributes to the Development of Experimental Dermal Fibrosis, Arthritis & Rheumatology, vol.44, issue.11, pp.3140-50, 2014.
DOI : 10.1002/art.38819

C. Beyer, G. Schett, O. Distler, and J. Distler, Animal models of systemic sclerosis: Prospects and limitations, Arthritis & Rheumatism, vol.47, issue.Suppl 5, pp.2831-2875, 2010.
DOI : 10.1002/art.27647

T. Yamamoto, Animal model of systemic sclerosis, The Journal of Dermatology, vol.125, issue.1, pp.26-41, 2010.
DOI : 10.1111/j.1346-8138.2009.00764.x

H. Ishikawa, K. Takeda, A. Okamoto, S. Matsuo, and K. Isobe, Induction of Autoimmunity in a Bleomycin-Induced Murine Model of Experimental Systemic Sclerosis: An Important Role for CD4+ T Cells, Journal of Investigative Dermatology, vol.129, issue.7, pp.1688-95, 2009.
DOI : 10.1038/jid.2008.431

T. Yamamoto, S. Takagawa, I. Katayama, K. Yamazaki, Y. Hamazaki et al., Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking Scleroderma, Journal of Investigative Dermatology, vol.112, issue.4, pp.456-62, 1999.
DOI : 10.1046/j.1523-1747.1999.00528.x

F. Fang, A. Shangguan, K. Kelly, J. Wei, K. Gruner et al., Early growth response 3 (Egr-3) is induced by transforming growth factor-beta and regulates fibrogenic responses

J. Avouac, M. Elhai, M. Tomcik, B. Ruiz, M. Friese et al., Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis, Annals of the Rheumatic Diseases, vol.72, issue.6, pp.1089-98, 2013.
DOI : 10.1136/annrheumdis-2012-201759

I. Thievessen, P. Thompson, S. Berlemont, K. Plevock, S. Plotnikov et al., Vinculin???actin interaction couples actin retrograde flow to focal adhesions, but is dispensable for focal adhesion growth, The Journal of Cell Biology, vol.111, issue.1, pp.163-77, 2013.
DOI : 10.1038/ncb1765

T. Yamamoto, M. Kuroda, and K. Nishioka, Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strains, Archives of Dermatological Research, vol.292, issue.11, pp.535-576, 2000.
DOI : 10.1007/s004030000183

M. Elhai, J. Avouac, U. Walker, M. Matucci-cerinic, G. Riemekasten et al., A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study, Annals of the Rheumatic Diseases, vol.43, issue.(Suppl 3), pp.1-7, 2014.
DOI : 10.1136/annrheumdis-2014-206386

S. Tofovic, X. Zhang, E. Jackson, H. Zhu, and G. Petrusevska, 2-methoxyestradiol attenuates bleomycin-induced pulmonary hypertension and fibrosis in estrogen-deficient rats, Vascular Pharmacology, vol.51, issue.2-3, pp.190-197, 2009.
DOI : 10.1016/j.vph.2009.06.002

G. Hughes and D. Choubey, Modulation of autoimmune rheumatic diseases by oestrogen and progesterone, Nature Reviews Rheumatology, vol.146, issue.12, pp.740-51, 2014.
DOI : 10.4049/jimmunol.164.12.6237

T. Yamamoto and K. Nishioka, Animal Model of Sclerotic Skin. IV: Induction of Dermal Sclerosis by Bleomycin is T Cell Independent, Journal of Investigative Dermatology, vol.117, issue.4, pp.999-1001, 2001.
DOI : 10.1046/j.0022-202x.2001.01509.x

T. Yamamoto, Bleomycin and the skin, British Journal of Dermatology, vol.87, issue.5, pp.869-75, 2006.
DOI : 10.1111/j.1600-0749.1991.tb00446.x

R. Lafyatis, Transforming growth factor ?????at the centre of systemic sclerosis, Nature Reviews Rheumatology, vol.50, issue.12, pp.706-725, 2014.
DOI : 10.1164/rccm.201011-1874OC